Cure TV

Can local and systemic therapies be combined to treat liver cancer?

Thomas Butler, M.D., medical oncologist at the University of Southern Alabama, Mitchell Cancer Institute, discusses the importance of shared decision making in cancer care.

There seems to be a shift in the field of oncology where patients are looking more toward being treated close to home rather than traveling to a large academic treatment center, explained Edward S. Kim, M.D., Chair of the Department of Solid Tumor Oncology at Levine Cancer Institute, at Association of Community Cancer Centers 34th National Oncology Conference.

Ashley Johnson, patient wellness navigator at Charleston Hematology and Oncology Associates, discusses how important it is for the whole health care team to better understand insurance and how patients pay for their cancer treatment.

Mellisa Wheeler, director of Disparities at the Levine Cancer Institute, discusses how her team came to recognize the need for a mobile lung cancer screening unit.

Older patients who are newly diagnosed with cancer often have special needs, says Janine Overcash, Ph.D., associate professor of clinical nursing and director of the Adult/Geriatric Nurse Practitioner Program at The Ohio State University.

Cancer care involves more than just doctors and nurses. Nadine Barrett, director of the Office of Health Equity and Disparities at the Duke Cancer Institute, knows this.

David Reardon, M.D., clinical director at the Center for Neuro-oncology at the Dana-Farber Cancer Institute, breaks down a common misconception that many people have about glioblastoma (GBM).

Renata Marie Vestevich, founder and developer of Essential Eyebrow Solution (EES), discusses how this topical solution may be able to help patients keep their eyebrow hair while undergoing chemotherapy.

Garrett Frampton, associate director of Cancer Genomics at Foundation Medicine, discusses recent research about genetic mutations that are more common in certain age groups.

Gary Rodin, M.D., head of the Department of Supportive Care at Princess Margaret Cancer Centre, in Toronto, Canada, discusses CALM, an intervention designed to help patients with advanced-stage cancer cope and talk about their concerns.

Yania Jansen, surgical trainee at Vrije Universiteit Brussel, in Brussels, Belgium, discusses the possibility of stopping treatment with Keytruda (pembrolizumab) for patients with melanoma.

David Reardon, M.D., clinical director at the Center for Neuro-oncology at the Dana-Farber Cancer Institute, offers advice for patients who have recently been diagnosed with glioblastoma (GBM).

Jeffrey Weber, M.D., Ph.D., Deputy Director of the Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, discusses how important it is that patients speak up when they experience side effects from their cancer treatments.

Renee Cowan, gynecologic oncology fellow at Memorial Sloan Kettering Cancer Center (MSK), discusses the importance of patients with ovarian cancer seeing an oncologist who specializes in the field.

Michael D. Becker, cancer survivor and author of “A Walk With Purpose: Memoir of a Bioentrepreneur” discusses how he realized that he had head and neck cancer.

Kathryn Burn, head of Partnerships and Research at Smart Patients, discusses her organization's role in the National Cancer Moonshot Initiative.

Andrea J. Wilson, president and founder of Blue Faery: The Adrienne Wilson Liver Cancer Association, offers advice for patients with liver cancer. Wilson started the foundation after her younger sister, Adrienne, died of liver cancer.

Researchers might be on to a new biomarker for patients with colorectal cancer, says Martin D. Berger, M.D., oncologist at the University of Southern California.

Gary A. Puckrein, Ph.D., president and CEO of the National Minority Quality Forum, says that cancer statistics are not the same across the nation.

Lauren Belive, Senior Federal Government Relations Manager at Lyft, discusses the company's Treatment Transport program.

Kathleen Gallagher, MPH, senior director of Health Services Research and Outcomes at the National Patient Advocate Foundation, discusses the importance of data sharing in advancing cancer care.

Beth Meagher, of Deloitte Consulting, discusses the importance of early cancer detection.

Lisa Richardson, M.D., M.P.H., director of the Centers for Disease Control and Prevention's (CDC) Division of Cancer Prevention and Control, discusses the CDC's role in the National Cancer Moonshot Initiative.

Patricia J. Goldsmith, CEO of CancerCare, discusses the importance of coordinating between health care professionals as a patient moves into survivorship and converts to treating cancer as a chronic illness.

Jeff Allen, president and CEO of Friends of Cancer Research, shares what he hopes continuing advancements and the Cancer Moonshot will achieve in cancer care.

Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Sidney Kimmel Cancer Center, discusses plans to maintain momentum on the Cancer Moonshot initiative.

Donna Cryer, CEO and president of the Global Liver Institute, discusses the importance of having diverse clinical trials in cancer care.